News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osmetech Plc (OMH) Chosen as Principal Supplier for a Major Clinical Trial



5/13/2009 10:01:31 AM

PASADENA, Calif.--(BUSINESS WIRE)--Osmetech plc (LSE:OMH) (“Osmetech” or the “Company”), the international molecular diagnostics company, announces that it has signed an agreement as principal supplier of Warfarin Sensitivity tests for a major new US trial sponsored by the US National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) in the US.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES